Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...

By Sabrina Valle NEW YORK, Jan 20 (Reuters) - Abivax Chief Executive Marc de Garidel dismissed as "noise" reports in the ...

Q2 was a strong quarter. Today we shared positive top line data from the ATTAIN-1 orforglipron trial in people with obesity.

Many peptides are produced either by compounding pharmacies in the U.S. or by an ever-growing number of factories in China.

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

The 221,000-square-foot industrial facility from Florida-based Loci Capital Group and Missouri-based Summit Real Estate Group ...

Postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, an obesity drug sold ...

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

Florida GOP Rep. Greg Steube said that it would be worth getting rid of the filibuster if it meant passing the Safeguard ...

A case in point is the dire need for new antimicrobials, but pharmaceutical companies have little financial incentive to ...

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...